TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/08/2025
Voltar para busca
Dado oficial do USPTO
OZETTE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
12/08/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
21/04/2022
Data de registro
21/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/05/2024
Última transação
12/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2023-05-00
Primeiro uso no comércio
2023-05-00
Código do desenho
4
Tipo de titular
03
Localização do titular
Seattle, WA
Examinador
AURAND, MEGAN
Unidade examinadora
O10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Ozette Technologies, Inc.
Representantes
Chelsea E. Carbone WILSON SONSINI GOODRICH & ROSATI
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Providing temporary use of non-downloadable computer software using artificial intelligence (AI) and machine learning for analyzing immune data for the purposes of medical researchdiagnosistreatment; providing temporary use of non-downloadable computer software using artificial intelligence (AI) and machine learning for analyzing immune data for the purposes of identifyingprescribing and monitoring medications; providing temporary use of non-downloadable computer software using artificial intelligence (AI) and machine learning for diagnosingmonitoring and treating diseases and disordersinfectious diseasecancerautoimmune disorderscardiovascular diseaseneurological disorders; scientific research and development; pharmaceutical research and development; medical research; medical and pharmaceutical research services; cloud hosting provider services for storinganalyzing and sharing biological information; providing an online network environment service featuring technology that enables users to storeanalyze and share data in the fields of life science; technical support servicesinfrastructure management services for monitoringadministration and management of cloud computing IT and application systems in the fields of life science; product design and development of laboratory apparatus and instruments and design and development of computer software systems for use in analysis of biomolecules; installation and maintenance of computer software and software databases used in the field of analysis of biomolecules; consultancyinformationadvisory services in the field of medical research analysis of biomoleculesdiseasesdisorderstreatment efficacy; product developmentdeveloping equipment for use in preparingdetectingsequencingquantifyinganalyzing proteins and other biological moleculesautomated laboratory equipment and systemscomputer systems for collectingstoringanalyzingreporting biological informationfor sample tracking and managing projectslaboratory workflow and data to the order and specification of othersall the foregoing in the fields of scientific and clinical research; medical and scientific research in the fields of vaccinespharmaceuticalsbiologicsvaccinesadjuvantsadjuvant formulationsbiologic formulationsdrug deliverydiagnosticsmedical therapeutics; product research and development in the fields of pharmaceuticalsvaccinesdiagnosticsadjuvantsadjuvant formulationsbiologic formulationsdrug delivery; custom design and development of chemical reagents and biochemical assays; testing of pharmaceuticals; scientific laboratory services; computer and scientific research in the field of artificial intelligence (AI) and machine learning for analysis of immune datadisease statestreatment response
Classe 44
Medical testing and reporting for diagnostic or treatment purposes; consultancyinformationadvisory services in the field of medical treatment of infectious diseasecancerautoimmune disorderscardiovascular diseaseneurological disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/08/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/08/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/08/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/08/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
21/05/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
17/04/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
16/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
23/03/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
22/03/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
22/03/2024
EX1G
SOU EXTENSION 1 GRANTED
22/03/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
29/02/2024
IUAF
USE AMENDMENT FILED
06/02/2024
DRRR
DIVISIONAL REQUEST RECEIVED
06/02/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
06/02/2024
EISU
TEAS STATEMENT OF USE RECEIVED
06/02/2024
EXT1
SOU EXTENSION 1 FILED
05/02/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/02/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22/08/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/06/2023
PUBO
PUBLISHED FOR OPPOSITION
27/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/05/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
25/05/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/05/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
25/05/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/02/2023
GNRT
NON-FINAL ACTION E-MAILED
23/02/2023
CNRT
NON-FINAL ACTION WRITTEN
23/02/2023
DOCK
ASSIGNED TO EXAMINER
08/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/04/2022
NWAP
NEW APPLICATION ENTERED
25/04/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OZETTE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.